104 related articles for article (PubMed ID: 16788393)
1. High-frequency cranial electrostimulation (CES) in patients with probable Alzheimer's disease.
Scherder EJ; van Tol MJ; Swaab DF
Am J Phys Med Rehabil; 2006 Jul; 85(7):614-8. PubMed ID: 16788393
[TBL] [Abstract][Full Text] [Related]
2. Cranial electrostimulation (CES) in patients with probable Alzheimer's disease.
Scherder EJ; Deijen JB; Vreeswijk SH; Sergeant JA; Swaab DF
Behav Brain Res; 2002 Jan; 128(2):215-7. PubMed ID: 11796166
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease: a pilot study.
Scherder E; Knol D; van Tol MJ; van Someren E; Deijen JB; Swaab D; Scheltens P
Dement Geriatr Cogn Disord; 2006; 22(4):267-72. PubMed ID: 16912480
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease.
Scherder E; Knol D; van Someren E; Deijen JB; Binnekade R; Tilders F; Sergeant J
Neurorehabil Neural Repair; 2003 Jun; 17(2):101-8. PubMed ID: 12814055
[TBL] [Abstract][Full Text] [Related]
5. Management of cognitive deficits and mood disturbance.
Meyers CA
Handb Clin Neurol; 2012; 104():363-9. PubMed ID: 22230454
[No Abstract] [Full Text] [Related]
6. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease.
Landes AM; Sperry SD; Strauss ME
J Neuropsychiatry Clin Neurosci; 2005; 17(3):342-9. PubMed ID: 16179656
[TBL] [Abstract][Full Text] [Related]
7. Peripheral electrical stimulation in Alzheimer's disease.
van Dijk KR; Scheltens P; Luijpen MW; Sergeant JA; Scherder EJ
Dement Geriatr Cogn Disord; 2005; 19(5-6):361-8. PubMed ID: 15802911
[TBL] [Abstract][Full Text] [Related]
8. Why Should I Care? Dimensions of Socio-Emotional Cognition in Younger-Onset Dementia.
Hutchings R; Hodges JR; Piguet O; Kumfor F; Boutoleau-Bretonniére C
J Alzheimers Dis; 2015; 48(1):135-47. PubMed ID: 26401935
[TBL] [Abstract][Full Text] [Related]
9. Effects of "isolated" transcutaneous electrical nerve stimulation on memory and affective behavior in patients with probable Alzheimer's disease.
Scherder EJ; Bouma A; Steen LM
Biol Psychiatry; 1998 Mar; 43(6):417-24. PubMed ID: 9532346
[TBL] [Abstract][Full Text] [Related]
10. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
Delbari A; Salman-Roghani R; Lokk J
Eur Neurol; 2011; 66(1):7-13. PubMed ID: 21701174
[TBL] [Abstract][Full Text] [Related]
11. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
12. Group activity and cognitive improvement among patients with Alzheimer's disease.
Gerber GJ; Prince PN; Snider HG; Atchison K; Dubois L; Kilgour JA
Hosp Community Psychiatry; 1991 Aug; 42(8):843-5. PubMed ID: 1894261
[No Abstract] [Full Text] [Related]
13. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
[TBL] [Abstract][Full Text] [Related]
14. Effects of transcutaneous electrical nerve stimulation (TENS) on memory in elderly with mild cognitive impairment.
Luijpen MW; Swaab DF; Sergeant JA; van Dijk KR; Scherder EJ
Behav Brain Res; 2005 Mar; 158(2):349-57. PubMed ID: 15698902
[TBL] [Abstract][Full Text] [Related]
15. Repetitive behaviour in Alzheimer's disease: description, correlates and functions.
Cullen B; Coen RF; Lynch CA; Cunningham CJ; Coakley D; Robertson IH; Lawlor BA
Int J Geriatr Psychiatry; 2005 Jul; 20(7):686-93. PubMed ID: 16021661
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline.
Cotelli M; Manenti R; Cappa SF; Zanetti O; Miniussi C
Eur J Neurol; 2008 Dec; 15(12):1286-92. PubMed ID: 19049544
[TBL] [Abstract][Full Text] [Related]
17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
18. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
19. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
[TBL] [Abstract][Full Text] [Related]
20. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment?
Holt J; Stiltner L; Wallace R; Raetz J
J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
